Compare Abeona Therapeutics Inc (ABEO) vs Vanguard Real Estate Index Fund ETF (VNQ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Vanguard Real Estate Index Fund ETF — how do they compare? Abeona Therapeutics Inc trades at $6.76 (market cap $373.32M), while Vanguard Real Estate Index Fund ETF trades at $97.16. Which is the better fit depends on your goals.
| ABEO | VNQ | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | — |
52-Week High | $7.23 | $98.66 |
52-Week Low | $4.17 | $87.00 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
VNQ (Vanguard Real Estate ETF) trades at $97.24, down 0.8% on the day, with technical indicators showing a bullish trend supported by moving averages. The ETF's recent performance reflects renewed investor interest in REITs amid shifting rate expectations, with June 2026 marking the sector's best monthly performance in years according to market data. Dividend payments remain a key attraction, with the next distribution scheduled for June 2026.
The outlook for VNQ appears cautiously optimistic as REIT fundamentals show resilience despite elevated interest rates. Investment opportunity lies in potential rate stabilization and sector rotation, while risks include persistent inflation pressure and Treasury yield volatility. Analyst sentiment is mixed, with some highlighting discounted valuations while others caution about sector-specific challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Vanguard Real Estate Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VNQ →
